200 related articles for article (PubMed ID: 21144476)
1. [The histaminergic system: a target for innovative treatments of cognitive deficits].
Motawaj M; Burban A; Davenas E; Gbahou F; Faucard R; Morisset S; Arrang JM
Therapie; 2010; 65(5):415-22. PubMed ID: 21144476
[TBL] [Abstract][Full Text] [Related]
2. Activation of brain histaminergic neurotransmission: a mechanism for cognitive effects of memantine in Alzheimer's disease.
Motawaj M; Burban A; Davenas E; Arrang JM
J Pharmacol Exp Ther; 2011 Feb; 336(2):479-87. PubMed ID: 21057059
[TBL] [Abstract][Full Text] [Related]
3. The histamine H3 receptor as a therapeutic drug target for CNS disorders.
Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D
Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activity of the histamine H3 receptor.
Arrang JM; Morisset S; Gbahou F
Trends Pharmacol Sci; 2007 Jul; 28(7):350-7. PubMed ID: 17573125
[TBL] [Abstract][Full Text] [Related]
5. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
[TBL] [Abstract][Full Text] [Related]
6. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
Gbahou F; Davenas E; Morisset S; Arrang JM
J Pharmacol Exp Ther; 2010 Sep; 334(3):945-54. PubMed ID: 20530654
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in histamine H3 receptor antagonists/inverse agonists.
Łazewska D; Kieć-Kononowicz K
Expert Opin Ther Pat; 2010 Sep; 20(9):1147-69. PubMed ID: 20716022
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat.
Giannoni P; Passani MB; Nosi D; Chazot PL; Shenton FC; Medhurst AD; Munari L; Blandina P
Eur J Neurosci; 2009 Jun; 29(12):2363-74. PubMed ID: 19490084
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of histamine H3 receptor antagonists in dementias.
Chazot PL
Drug News Perspect; 2010 Mar; 23(2):99-103. PubMed ID: 20369074
[TBL] [Abstract][Full Text] [Related]
10. Histamine and schizophrenia.
Arrang JM
Int Rev Neurobiol; 2007; 78():247-87. PubMed ID: 17349864
[TBL] [Abstract][Full Text] [Related]
11. CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease.
Motawaj M; Peoc'h K; Callebert J; Arrang JM
J Alzheimers Dis; 2010; 22(3):861-71. PubMed ID: 20858978
[TBL] [Abstract][Full Text] [Related]
12. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
[TBL] [Abstract][Full Text] [Related]
13. H3 receptor antagonists/inverse agonists as anti-obesity agents.
Hancock AA
Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of histaminergic compounds in the treatment of addiction and drug-related cognitive disorders.
Alleva L; Tirelli E; Brabant C
Behav Brain Res; 2013 Jan; 237():357-68. PubMed ID: 23000530
[TBL] [Abstract][Full Text] [Related]
15. [The histamine H(3) receptor: a target for new drugs].
Arrang JM
Ann Pharm Fr; 2003 May; 61(3):173-84. PubMed ID: 12714930
[TBL] [Abstract][Full Text] [Related]
16. Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system.
Witkin JM; Nelson DL
Pharmacol Ther; 2004 Jul; 103(1):1-20. PubMed ID: 15251226
[TBL] [Abstract][Full Text] [Related]
17. Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease.
Brioni JD; Esbenshade TA; Garrison TR; Bitner SR; Cowart MD
J Pharmacol Exp Ther; 2011 Jan; 336(1):38-46. PubMed ID: 20864505
[TBL] [Abstract][Full Text] [Related]
18. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk GL
J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
[TBL] [Abstract][Full Text] [Related]
19. High constitutive activity of native H3 receptors regulates histamine neurons in brain.
Morisset S; Rouleau A; Ligneau X; Gbahou F; Tardivel-Lacombe J; Stark H; Schunack W; Ganellin CR; Schwartz JC; Arrang JM
Nature; 2000 Dec; 408(6814):860-4. PubMed ID: 11130725
[TBL] [Abstract][Full Text] [Related]
20. [Molecular imaging of histamine receptors in the human brain].
Tashiro M; Yanai K
Brain Nerve; 2007 Mar; 59(3):221-31. PubMed ID: 17370648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
